Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy

BACKGROUND: Retreatment with ipilimumab has been shown to re-establish disease control in some patients with disease progression. Here, we report the efficacy and safety of retreatment with ipilimumab 3 mg kg(−1) among patients participating in an expanded access programme in Italy. METHODS: Patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiarion-Sileni, V, Pigozzo, J, Ascierto, P A, Simeone, E, Maio, M, Calabrò, L, Marchetti, P, De Galitiis, F, Testori, A, Ferrucci, P F, Queirolo, P, Spagnolo, F, Quaglino, P, Carnevale Schianca, F, Mandalà, M, Di Guardo, L, Del Vecchio, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974075/
https://www.ncbi.nlm.nih.gov/pubmed/24619072
http://dx.doi.org/10.1038/bjc.2014.126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974075/
https://www.ncbi.nlm.nih.gov/pubmed/24619072
http://dx.doi.org/10.1038/bjc.2014.126

Ejemplares similares